Structural Heart Disease: Top Stories & Trends

News You Need to Know Today

Wednesday, May 11, 2022

Editor's Choice: Structural Heart Disease

Cardiologists and surgeons perform first TAVR using CT imaging guidance on HF patient with blood clot

“We believe this case is potentially groundbreaking," one interventional cardiologist said.

transcatheter aortic valve replacement (TAVR) procedure guided by CT fusion imaging on a patient with heart failure and a blood clot. CT fusion imaging-guided deployment of the Sentinel Cerebral Protection System during a TAVR procedure. Image courtesy of Vasudev et al.

Cardiologists and surgeons perform first TAVR using CT imaging guidance on HF patient with blood clot

“We believe this case is potentially groundbreaking," one interventional cardiologist said.

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead.

Illustration showing four innovative heart failure technologies: The V-Wave interaterial shunt to relieve pressures between the left and right sides of the heart; the Carillon Transcatheter mitral valve annuloplasty system; the Revivent TC system and the AccuCinch device. Interventional cardiology heart failure cleveland clinic

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead.

Interventional cardiologists complete first heart procedure of its kind in North America

While the system used during the procedure has not yet gained full FDA approval, this patient was treated under a compassionate-use clearance from the agency.

TricValve Transcatheter Bicaval Valves System Cleveland Clinic. Image courtesy of P + F Products + Features GmbH.

Interventional cardiologists complete first heart procedure of its kind in North America

While the system used during the procedure has not yet gained full FDA approval, this patient was treated under a compassionate-use clearance from the agency.

Medtronic recalls Harmony transcatheter pulmonary valve's delivery catheter after multiple complaints, 1 injury

Customers have been asked to return all unused devices and pause any new clinical trials involving the Harmony TPV.

The Medtronic Harmony transcatheter pulmonary valve on display at ACC 2022. The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling the delivery catheter from its Harmony transcatheter pulmonary valve (TPV) system due to a risk of the piece breaking during use.

Medtronic recalls Harmony transcatheter pulmonary valve's delivery catheter after multiple complaints, 1 injury

Customers have been asked to return all unused devices and pause any new clinical trials involving the Harmony TPV.

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial will study the use of T AVR in patients with moderate, symptomatic aortic stenosis.

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes.

The Boston Scientific Watchman device is a transcatheter device implanted in the left atrial appendage (LAA) to seal it off so atrial fibrillation patients can got off of anticoagulant therapy.

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes.

Same-day discharge after LAAO associated with strong outcomes, significant cost savings

A new analysis found that 30-day outcomes do not significantly change when LAAO patients go home the same day as their procedure.

Illustration of a left atrial appendage occlusion (LAAO) procedure using a Watchman device. Image courtesy of Johns Hopkins Medicine. #LAA #LAAO

Same-day discharge after LAAO associated with strong outcomes, significant cost savings

A new analysis found that 30-day outcomes do not significantly change when LAAO patients go home the same day as their procedure.

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

The median time from heart valve implantation to balloon dilatation was 4.6 months.

Balloon valvuloplasty months after implantation is a safe and effective treatment option for patients with transcatheter heart valve (THV) dysfunction, according to a new analysis published in the Journal of the American College of Cardiology

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

The median time from heart valve implantation to balloon dilatation was 4.6 months.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Editor's Choice: Structural Heart Disease

Recent Newsletters